Zheng Yongli, Gu Rui, Wu Taixiang
Infectious Disease Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, China, 610041.
Cochrane Database Syst Rev. 2009 Oct 7(4):CD005531. doi: 10.1002/14651858.CD005531.pub3.
Measles is an infectious disease caused by the Morbilli virus. Chinese physicians believe that medicinal herbs are effective in alleviating symptoms and preventing complications. Chinese herbal medicines are dispensed according to the particular symptoms. This is an update of a Cochrane review first published in 2006.
To assess the effectiveness and possible adverse effects of Chinese medicinal herbs in treating measles.
We searched the Cochrane Central Register of Controlled Clinical Trials (CENTRAL) (The Cochrane Library 2009, issue 1) which contains the Cochrane Acute Respiratory Infection Group's Specialised Register; MEDLINE (1966 to March 2009); EMBASE (1980 to March 2009); the Chinese Biomedical Database (1976 to March 2009); VIP Information (1989 to March 2009); and China National Knowledge Infrastructure (CNKI) (1994 to March 2009). We searched the metaRegister of Controlled Trials for ongoing trials.
Randomised controlled trials (RCTs) in which patients with measles without complications were treated with Chinese medicinal herbs.
Three review authors (YZ, RG, TW) independently assessed trial quality and extracted data. We telephone interviewed the study authors for missing information regarding participant allocation. Some trials allocated participants according to the sequence they were admitted to the trials, that is to say, by using a pseudo-random allocation method; none of the trials concealed the allocation or blinding method.
We did not identify any suitable trials for inclusion. In this updated review we identified 61 trials which claimed to use random allocation. We contacted 29 trial authors by telephone and learned that the allocation methods used were not randomised. We excluded 34 studies because the patients experienced complications such as pneumonia. Both reasons excluded 10 studies. Another study was excluded because the trial author had not confirmed the diagnosis of measles. We were unable to contact the remaining seven trials' authors, so that they require further assessment and, meanwhile are allocated to the 'Studies awaiting classification' section.
AUTHORS' CONCLUSIONS: There is no evidence from RCTs for or against Chinese medicinal herbs as a treatment for measles. We hope high quality, robust RCTs in this field will be conducted in the future.
麻疹是一种由麻疹病毒引起的传染病。中国医生认为草药在缓解症状和预防并发症方面有效。中药根据特定症状进行配药。这是对2006年首次发表的Cochrane系统评价的更新。
评估中药治疗麻疹的有效性和可能的不良反应。
我们检索了Cochrane临床对照试验中心注册库(CENTRAL)(《Cochrane图书馆》2009年第1期),其中包含Cochrane急性呼吸道感染小组的专业注册库;MEDLINE(1966年至2009年3月);EMBASE(1980年至2009年3月);中国生物医学数据库(1976年至2009年3月);维普资讯(1989年至2009年3月);以及中国知网(CNKI)(1994年至2009年3月)。我们检索了对照试验元注册库以查找正在进行的试验。
对无并发症的麻疹患者使用中药进行治疗的随机对照试验(RCT)。
三位综述作者(YZ、RG、TW)独立评估试验质量并提取数据。我们通过电话采访研究作者以获取有关参与者分配的缺失信息。一些试验根据参与者进入试验的顺序进行分配,也就是说,使用了伪随机分配方法;没有一项试验对分配或盲法进行了隐藏。
我们未识别出任何适合纳入的试验。在本次更新的综述中,我们识别出61项声称使用随机分配的试验。我们通过电话联系了29位试验作者,得知所使用的分配方法并非随机。我们排除了34项研究,因为患者出现了诸如肺炎等并发症。这两个原因共排除了10项研究。另一项研究被排除,因为试验作者未确认麻疹的诊断。我们无法联系其余7项试验的作者,因此它们需要进一步评估,同时被分配到“等待分类的研究”部分。
随机对照试验中没有证据支持或反对使用中药治疗麻疹。我们希望未来能在该领域开展高质量、可靠的随机对照试验。